IL313314A - Solid forms of pyrazolo[3,4-d]pyrimidine compounds - Google Patents
Solid forms of pyrazolo[3,4-d]pyrimidine compoundsInfo
- Publication number
- IL313314A IL313314A IL313314A IL31331424A IL313314A IL 313314 A IL313314 A IL 313314A IL 313314 A IL313314 A IL 313314A IL 31331424 A IL31331424 A IL 31331424A IL 313314 A IL313314 A IL 313314A
- Authority
- IL
- Israel
- Prior art keywords
- pyrazolo
- solid forms
- pyrimidine compounds
- pyrimidine
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163290136P | 2021-12-16 | 2021-12-16 | |
| PCT/US2022/081795 WO2023114995A1 (en) | 2021-12-16 | 2022-12-16 | Solid forms of pyrazolo[3,4-d]pyrimidine compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL313314A true IL313314A (en) | 2024-08-01 |
Family
ID=85172741
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL313314A IL313314A (en) | 2021-12-16 | 2022-12-16 | Solid forms of pyrazolo[3,4-d]pyrimidine compounds |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US12012412B2 (https=) |
| EP (1) | EP4448529A1 (https=) |
| JP (1) | JP2024546844A (https=) |
| KR (1) | KR20240119299A (https=) |
| CN (1) | CN118401525A (https=) |
| AU (2) | AU2022416644B2 (https=) |
| CA (1) | CA3242577A1 (https=) |
| IL (1) | IL313314A (https=) |
| MX (1) | MX2024007517A (https=) |
| TW (1) | TW202333676A (https=) |
| WO (1) | WO2023114995A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12012412B2 (en) * | 2021-12-16 | 2024-06-18 | Pfizer Inc. | Solid forms of pyrazolo[3,4-d]pyrimidine compounds |
| AU2024329573A1 (en) * | 2023-08-22 | 2026-04-02 | Cardurion Pharmaceuticals, Inc. | Pyrazolo[3,4-d]pyrimidinone compounds for the treatment of chronic heart failure |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| RS52166B (sr) * | 2007-05-11 | 2012-08-31 | Pfizer Inc. | Amino-heterociklična jedinjenja |
| CN109893653A (zh) * | 2017-12-11 | 2019-06-18 | 王慧敏 | Pde9抑制剂的新用途 |
| US12012412B2 (en) | 2021-12-16 | 2024-06-18 | Pfizer Inc. | Solid forms of pyrazolo[3,4-d]pyrimidine compounds |
-
2022
- 2022-12-16 US US18/082,622 patent/US12012412B2/en active Active
- 2022-12-16 CN CN202280083751.7A patent/CN118401525A/zh active Pending
- 2022-12-16 AU AU2022416644A patent/AU2022416644B2/en active Active
- 2022-12-16 IL IL313314A patent/IL313314A/en unknown
- 2022-12-16 EP EP22854339.3A patent/EP4448529A1/en active Pending
- 2022-12-16 JP JP2024535383A patent/JP2024546844A/ja active Pending
- 2022-12-16 WO PCT/US2022/081795 patent/WO2023114995A1/en not_active Ceased
- 2022-12-16 MX MX2024007517A patent/MX2024007517A/es unknown
- 2022-12-16 TW TW111148528A patent/TW202333676A/zh unknown
- 2022-12-16 CA CA3242577A patent/CA3242577A1/en active Pending
- 2022-12-16 KR KR1020247023041A patent/KR20240119299A/ko active Pending
-
2024
- 2024-05-06 US US18/655,795 patent/US20240300961A1/en active Pending
-
2025
- 2025-12-03 AU AU2025275149A patent/AU2025275149A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| MX2024007517A (es) | 2024-08-19 |
| AU2022416644A1 (en) | 2024-07-04 |
| NZ812114A (en) | 2025-08-29 |
| AU2025275149A1 (en) | 2026-01-08 |
| CA3242577A1 (en) | 2023-06-22 |
| KR20240119299A (ko) | 2024-08-06 |
| EP4448529A1 (en) | 2024-10-23 |
| TW202333676A (zh) | 2023-09-01 |
| CN118401525A (zh) | 2024-07-26 |
| JP2024546844A (ja) | 2024-12-26 |
| US12012412B2 (en) | 2024-06-18 |
| US20230192707A1 (en) | 2023-06-22 |
| WO2023114995A1 (en) | 2023-06-22 |
| AU2022416644B2 (en) | 2025-09-11 |
| US20240300961A1 (en) | 2024-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3980010A4 (en) | 2,3,5-TRISUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINE COMPOUNDS | |
| DK4139309T3 (da) | [1,3]diazino[5,4-d]pyrimidiner som her2-inhibitorer | |
| MA71388A (fr) | Composés pyrido[4,3-d]pyrimidines | |
| JOP20190144A1 (ar) | إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز | |
| JOP20190143B1 (ar) | مثبطات جزيئات صغيرة من عائلة jak لإنزيمات الكيناز | |
| EP3543242C0 (en) | COMPOUND 8,9-DIHYDROIMIDAZOLE [1,2-A]PYRIMIDO [5,4-E]PYRIMIDINE -5 (6H)-KETONE | |
| EP3744723A4 (en) | SUBSTITUTED MACROCYCLIC PYRAZOLO [1,5-A] PYRIMIDINE COMPOUND | |
| DK1689751T3 (da) | 5,7-diaminpyrazolo[4,3-D]pyrimidiner med PDE-5-inhiberende aktivitet | |
| EA201170771A1 (ru) | Органические соединения | |
| IL313314A (en) | Solid forms of pyrazolo[3,4-d]pyrimidine compounds | |
| EA201890827A1 (ru) | Конденсированные производные пиразола в качестве ингибиторов киназы | |
| IL289456A (en) | Eif4e-inhibiting 4-oxo-3,4-dihydropyrido[3,4-d]pyrimidine compounds | |
| MX386181B (es) | Formas cristalinas de un inhibidor de quinasa janus | |
| EP3508487A4 (en) | PYRAZOLO [1,5-A] PYRIMIDINE COMPOUND | |
| IL276160A (en) | A salt of the compound pyrazolo[5,1-]pyrimidine and its crystals | |
| DK3596080T3 (da) | Farmakologisk aktive alicyclisk-substitueret pyrazolo[1,5-a]pyrimidin-derivater | |
| EP4277905A4 (en) | PYRAZOLO[3,4-D PYRIMIDINE-6-YL-SULFONAMIDE DERIVATIVES FOR SGK-1 INHIBITION | |
| MX2019005123A (es) | Compuestos de [1,2,4]triazolo[1,5-a]pirimidina como inhibidores de pde2. | |
| BRPI0516242A (pt) | compostos tieno-pirimidina tendo atividade fungicida | |
| EP3568400C0 (en) | PROCESS FOR PREPARING 5-AMINO-6H-THIAZOLO[4,5-D]PYRIMIDINE-2,7-DIONE COMPOUNDS WITH POSITION 3 | |
| IL287887A (en) | Synthesis of labeled imidazo[2,1-a]pyrimidines | |
| PT4192833T (pt) | Derivados de pirazolo[1,5-a]pirimidina substituídos com heterocíclico farmacologicamente ativos | |
| EP3590516A4 (en) | ANTI-TUMOR ACTIVATOR USING A PYRAZOLO [3,4-D] PYRIMIDINE COMPOUND | |
| DK1678182T3 (da) | Fremgangsmåde til fremstilling af substituerede 5-amino-pyrazolo[4,3-E]-1,2,4-triazolo-[1,5-C]pyrimidiner | |
| DK1742950T3 (da) | Pyrazolo-[4,3-D]-pyrimidiner |